Clinical Trials Directory

Trials / Completed

CompletedNCT02124473

Addition of Homeopathy in Patients With Resistant Arterial Hypertension

Phase II Randomized, Double-Blind, Placebo-Controlled Trial of Homeopathy in Resistant Arterial Hypertension

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
79 (actual)
Sponsor
Macmillan Research Group UK · Industry
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Resistant hypertension (RHTN) is a common clinical problem faced by both primary care clinicians and specialists worldwide. Patients with RHTN have higher rates of cardiovascular events and mortality compared with patients with more easily controlled hypertension. In addition, RHTN is often complicated by metabolic abnormalities. Homeopathy, although widely used in hypertension, but no study has been taken to evaluate the impact on resistant hypertension. The aim of this trial was to evaluate individualized homeopathy on BP in patients with resistant hypertension.

Conditions

Interventions

TypeNameDescription
OTHERHomeopathy
OTHERPlacebo

Timeline

Start date
2013-08-01
Primary completion
2014-01-01
Completion
2014-03-01
First posted
2014-04-28
Last updated
2014-04-28

Locations

2 sites across 1 country: India

Source: ClinicalTrials.gov record NCT02124473. Inclusion in this directory is not an endorsement.

Addition of Homeopathy in Patients With Resistant Arterial Hypertension (NCT02124473) · Clinical Trials Directory